Result of phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small cell lung cancer.
Yan Sun
No relevant relationships to disclose
Ying Cheng
No relevant relationships to disclose
Xuezhi Hao
No relevant relationships to disclose
Jie Wang
No relevant relationships to disclose
Chengping Hu
No relevant relationships to disclose
Baohui Han
No relevant relationships to disclose
Xiaoqing Liu
No relevant relationships to disclose
Li Zhang
No relevant relationships to disclose
Huiping Wan
No relevant relationships to disclose
Zhongjun Xia
No relevant relationships to disclose
Yunpeng Liu
No relevant relationships to disclose
Wei Li
No relevant relationships to disclose
Mei Hou
No relevant relationships to disclose
Helong Zhang
No relevant relationships to disclose
Qingyu Xiu
No relevant relationships to disclose
Yunzhong Zhu
No relevant relationships to disclose
Jifeng Feng
No relevant relationships to disclose
Shukui Qin
No relevant relationships to disclose